CN101185710A - Powder agent medicine for treating chronic otitis media suppurative - Google Patents
Powder agent medicine for treating chronic otitis media suppurative Download PDFInfo
- Publication number
- CN101185710A CN101185710A CNA2007103010927A CN200710301092A CN101185710A CN 101185710 A CN101185710 A CN 101185710A CN A2007103010927 A CNA2007103010927 A CN A2007103010927A CN 200710301092 A CN200710301092 A CN 200710301092A CN 101185710 A CN101185710 A CN 101185710A
- Authority
- CN
- China
- Prior art keywords
- otitis media
- powder agent
- medicine
- grams
- chronic suppurative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention relates to a traditional Chinese medicine preparation, namely, a pulvis medicine used for treating chronic suppurative otitis media, which is made from the raw materials with the following weight proportions: 30 grams of grassleaf sweetfalg rhizome and cornus officinalis respectively, 20 grams of lightyellow sophora root and nutgall respectively, and 50 grams of yellow croaker ear-stone. The invention is characterized in that the formula is novel; the production cost is low; the preparation is easy; the employment is convenient; and the effect is remarkable.
Description
Technical field:
The present invention relates to a kind of Chinese medicine preparation, promptly treat the very good a kind of powder agent medicine for the treatment of chronic suppurative otitis media of chronic suppurative otitis media effect.
Background technology:
Chronic suppurative otitis media is middle ear mucosa, tela submucosa or the chronic suppurative inflammation that is deep to sclerotin, decays to performance characteristic with the perforation of ear drum, permanent current pus, audition, is the disease of a kind of commonly encountered diseases even very easily concurrent other disease.At present, the medicine for the treatment of chronic suppurative otitis media both at home and abroad is more, but has shortcomings such as drug price height, medical expense is big, effect is not ideal enough.
Summary of the invention:
The objective of the invention is at the present weak point on the treatment chronic suppurative otitis media, and the powder agent medicine and the preparation method of a kind of new raw material of Chinese medicine combination, treatment chronic suppurative otitis media evident in efficacy are provided.
Technical scheme of the present invention is achieved in that
A kind of powder agent medicine for the treatment of chronic suppurative otitis media, its medicine are to be made by the raw material of following weight parts: Rhizoma Acori Graminei, each 30 gram of Fructus Corni, Radix Sophorae Flavescentis, each 20 gram of Galla Chinensis, Asteriscus Pseudosciaenae 50 grams.
A kind of powder agent medicine for the treatment of chronic suppurative otitis media, the preparation method of its medicine is: with the oven dry of above-mentioned raw material of Chinese medicine, be ground into thin medicated powder, cross 120 mesh sieves, it is standby to bottle, powder agent medicine.
A kind of powder agent medicine for the treatment of chronic suppurative otitis media, its Therapeutic Principle is vital energy regualting and blood circulation-promoting, dehumidifying antiinflammatory.On composition of raw materials, follow the property of medicine through belonging to, lay particular stress on vital energy regualting and blood circulation-promoting, take into account whole machine balancing, the dehumidifying antiinflammatory of stopping over.Rhizoma Acori Graminei has vital energy regualting and blood circulation-promoting, diffusing wind damp eliminating effect in the medicine, and Fructus Corni has arresting seminal emission gas, solid collapse effect, and Radix Sophorae Flavescentis has heat clearing and damp drying, insecticidal action, and Galla Chinensis has the hemostasis Detoxication, and Asteriscus Pseudosciaenae has treating stranguria antiinflammation.Above-mentioned Chinese medicine is through dialectical compatibility, complements each other using, and medicine is directly invested focus, thereby given play to the effect of vital energy regualting and blood circulation-promoting, dehumidifying antiinflammatory effectively, to reach the purpose of curing chronic suppurative otitis media.
The present invention has following characteristics: prescription is new, cost is low, preparation is easy, easy to use, evident in efficacy.
Using method:
Every day 2 times, each consumption 0.2-0.3 gram.Method: elder generation wipes away external auditory meatus with absorbent liquor ball dried, and the reuse absorbent liquor ball dips in medicated powder and is blown into the ear intracavity, gets final product.
The taboo item:
1, fried sticky, the cold solid food hard, nondigestible and excitatory of taboo edible oil during the medication.
2, forbid taking orally.
Clinical therapeutic efficacy:
Criterion of therapeutical effect: a kind of curative effect for the treatment of the powder agent medicine treatment chronic suppurative otitis media of chronic suppurative otitis media judges whether mainly be dependent on the chronic suppurative otitis media symptom disappears.Medication 7 days was 1 course of treatment.Concrete curative effect is divided following three grades: cure---and the chronic suppurative otitis media symptom all disappears; Taking a turn for the better---the chronic suppurative otitis media symptom obviously alleviates; Invalid---after medication 1 course of treatment, the chronic suppurative otitis media symptom has no to disappear.
Effect: with Drug therapy chronic suppurative otitis media patient 27 examples of the present invention, treat 1 course of treatment, wherein cure 22 examples, 5 examples that take a turn for the better, cure rate is 81%, effective percentage is 100%.
Model case:
Yu, man, 23 years old, company clerk.Go to a doctor in March, 2006.Patient's readme is violated the ear disease and was had a surplus in existing 1 year, and frequent middle ear discomfort is often felt ear outflow clear liquid.Effusive liquid thickness more and more from ear within the next few days, audition obviously reduces.Be diagnosed as chronic suppurative otitis media after the indagation.Adopt powder agent medicine of the present invention, earlier with 5 days, symptom disappears substantially, for consolidating effect, the medication 2 days that continues again, all recover as before.
Claims (1)
1. a powder agent medicine for the treatment of chronic suppurative otitis media is characterized in that this medicine is to be made by the raw material of following weight parts: Rhizoma Acori Graminei, each 30 gram of Fructus Corni, Radix Sophorae Flavescentis, each 20 gram of Galla Chinensis, Asteriscus Pseudosciaenae 50 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007103010927A CN101185710B (en) | 2007-12-11 | 2007-12-11 | Powder medicine for treating chronic suppurative otitis media |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007103010927A CN101185710B (en) | 2007-12-11 | 2007-12-11 | Powder medicine for treating chronic suppurative otitis media |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101185710A true CN101185710A (en) | 2008-05-28 |
| CN101185710B CN101185710B (en) | 2012-05-30 |
Family
ID=39478467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007103010927A Expired - Fee Related CN101185710B (en) | 2007-12-11 | 2007-12-11 | Powder medicine for treating chronic suppurative otitis media |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101185710B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107496616A (en) * | 2017-09-08 | 2017-12-22 | 刘娟 | A kind of Chinese medicine for treating otitis media purulenta chronica |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100382823C (en) * | 2005-09-08 | 2008-04-23 | 广州中一药业有限公司 | Chinese medicine for treating cataract and its prepn |
-
2007
- 2007-12-11 CN CN2007103010927A patent/CN101185710B/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107496616A (en) * | 2017-09-08 | 2017-12-22 | 刘娟 | A kind of Chinese medicine for treating otitis media purulenta chronica |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101185710B (en) | 2012-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101152218A (en) | Traditional Chinese medicine for treating chronic suppurative otitis media | |
| CN101185710B (en) | Powder medicine for treating chronic suppurative otitis media | |
| CN101306143B (en) | Ear drops for treating otitis media suppurativa acuta | |
| CN101185708B (en) | Powder agent medicine for treating acute otitis media suppurative | |
| CN101194987B (en) | Powder medicament for treating recurrent mouth ulcer | |
| CN101194980B (en) | Powder medicament for treating otitis media suppurative | |
| CN101199685B (en) | Smoked washing medicament for treating chronicity conjunctivitis | |
| CN101204472B (en) | External drug for soft furuncle inflammation | |
| CN101185704B (en) | Powder agent medicine for treating aphtha | |
| CN101199695B (en) | Powders medicament for treating sinusitis | |
| CN101185666B (en) | Collunarium medicine for treating acute rhinitis | |
| CN101185697B (en) | Ointment medicine for treating anal fissure | |
| CN101194981B (en) | Powder medicament for treating otitis media chronica | |
| CN103202895B (en) | Spray for treating heart disease | |
| CN102233003A (en) | Pulmonary tuberculosis curing medicine | |
| CN101961474B (en) | Chinese medicinal preparation for treating gastrointestinal diseases | |
| CN101199650B (en) | Tincture dose medicament for treating scapulohumeral periarthritis | |
| CN101195009B (en) | Powder medicament for treating scrotum eczema | |
| CN101199633B (en) | Paste medicament for treating folliculitis | |
| CN101204399B (en) | External medicine for tinea pedis | |
| CN101185680A (en) | Collunarium medicine for treating chronic rhinitis | |
| CN101185691A (en) | Powder agent medicine for treating infantile aphtha | |
| CN101204441A (en) | External medicine for herpes zoster | |
| CN101194975B (en) | Powder medicament for treating impetigo | |
| CN101204478B (en) | A nose fumigating medicine for treating chronic sinusitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120530 Termination date: 20121211 |